Bacterial News and Research

RSS

Do aerosol boxes prevent airborne spread of SARS-CoV-2?

An interesting new study describes a novel aerosol box design that has been produced and tested to prevent airborne transmission of SARS-CoV-2.

24 Aug 2021

Study identifies a key molecular mechanism driving COVID-19 mortality

An enzyme with an elusive role in severe inflammation may be a key mechanism driving COVID-19 severity and could provide a new therapeutic target to reduce COVID-19 mortality.

24 Aug 2021

Synthetic SARS-CoV-2 vs. SARS-CoV-2

Though vaccination efforts are underway in most countries, there are still limited options for treating COVID-19. Now, researchers at Penn State designed a new COVID-19 therapy that uses a defective synthetic version of the SARS-CoV-2 virus to interfere with the actual virus's replication.

23 Aug 2021

Human milk oligosaccharides may help treat or prevent bacterial infections in newborns and adults

Bacteria known as group B Streptococcus (GBS) are a common cause of blood infections, meningitis and stillbirth in newborns. Although GBS infections can often be treated or prevented with antibiotics, the bacteria are becoming increasingly resistant.

23 Aug 2021

A combination of oral bacteria and intranasal vaccine provide protection from influenza A virus and COVID-19

A new study published in the journal mBio focuses on the role of nasal bacteria in eliciting virus-specific adaptive immunity.

20 Aug 2021

Research finds potential overuse of antibiotics in patients with severe SARS-CoV-2 pneumonia

Only 21 percent of patients with severe pneumonia caused by SARS-CoV-2 (the virus that causes COVID-19) have a documented bacterial superinfection at the time of intubation, resulting in potential overuse of antibiotics, according to new research published online in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine.

20 Aug 2021

Study explores the role of nasal bacteria and provides clues to developing better flu, COVID-19 vaccines

While gut microbiota play a critical role in the induction of adaptive immune responses to influenza virus infection, the role of nasal bacteria in the induction of virus-specific adaptive immunity is less clear.

17 Aug 2021

New nanobiotechnology shows remarkable ability to battle dangerous fungal infections

They’re roughly the same size as a coronavirus particle, and 1000 times smaller than a human hair, yet newly engineered nanoparticles developed by scientists at the University of South Australia, are punching well above their weight when it comes to treating drug-resistant fungal infections.

17 Aug 2021

Research suggests toll-like receptor 4 appears to play role in severe COVID

A group of researchers re-evaluated their previously proposed hypothesis, which stated that the TLR4 activated by the spike glycoprotein S1 domain increases ACE2 expression and, thereby, aids in COVID-19 infection.

16 Aug 2021

Certain intestinal bacteria induce cross-reactive IgA responses to the SARS-CoV-2 spike RBD

A new study finds that human gut bacteria can induce antibodies of the immunoglobulin A (IgA) subtype that cross-react with the SARS-CoV-2 spike RBD.

15 Aug 2021

Study tracks microbial population dynamics under prolonged starvation

A study of microbial populations under a prolonged period of starvation by Indiana University professor Jay T. Lennon and his laboratory could help researchers answer questions pertaining to chronic infections, the functioning of bacteria in the environment and the persistence of life itself.

14 Aug 2021

Scientists document person-to-person transmission of antimicrobial-resistant pneumonic plague

Although the world is focused on the COVID-19 pandemic, there are many other dangerous pathogens still out there, like Yersinia pestis, which causes plague – the deadly disease that killed tens of millions of people during the infamous Black Death in the 14th century.

13 Aug 2021

Bacterial News and Research

Do aerosol boxes prevent airborne spread of SARS-CoV-2?

Study identifies a key molecular mechanism driving COVID-19 mortality

Synthetic SARS-CoV-2 vs. SARS-CoV-2

Human milk oligosaccharides may help treat or prevent bacterial infections in newborns and adults

A combination of oral bacteria and intranasal vaccine provide protection from influenza A virus and COVID-19

Research finds potential overuse of antibiotics in patients with severe SARS-CoV-2 pneumonia

Study explores the role of nasal bacteria and provides clues to developing better flu, COVID-19 vaccines

New nanobiotechnology shows remarkable ability to battle dangerous fungal infections

Research suggests toll-like receptor 4 appears to play role in severe COVID

Certain intestinal bacteria induce cross-reactive IgA responses to the SARS-CoV-2 spike RBD

Study tracks microbial population dynamics under prolonged starvation

Scientists document person-to-person transmission of antimicrobial-resistant pneumonic plague

Link between high-fat diet, gut microbiota and cardiovascular disease revealed

New genomic and geological mapping tool may help track the deadliest of foodborne pathogens

Emerging biosensing technologies could revolutionize the diagnosis of neonatal sepsis

Enzyme pre-treatment yields a highly precise picture of skin bacteria

Patient laments on not getting the COVID-19 vaccine

Researchers bind anti-bacterial molecules with graphene to destroy bacteria on implants

New compound inspired by tapeworm drugs shows two-pronged effectiveness against COVID-19

Surfactant-coated nanoparticle applications in nanomedicine and food

Industry Focus eBook - Cell biology (5th edition) eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News